ASRT Assertio Holdings, Inc.: Accounting Value per Share

Assertio (ASRT) - corporate logo

The calculated book value per share of Assertio Holdings, Inc. (ASRT) demonstrates current capital stability, where the 11.71 indicator expresses the state of the metric. Price action is constrained by debt obligations and patent disputes, yet the business relies on a stable US domestic market, ignoring geopolitical turmoil. Management's pragmatic approach to M&A transactions and asset optimization confirms the leadership's competence in managing the holding company.

Assertio Therapeutics (ASRT) Equity per Share: for the period 07/04/2022 - 06/27/2026

Assertio Holdings - analytical breakdowns and key metrics (ASRT)

- price and consensus price forecast:
Price Chart Assertio Therapeutics|ASRT - Fair Value Consensus
- market capitalization data:
Market Valuation Assertio Holdings, Inc.|ASRT - Aggregate Business Value
- book capitalization data:
Net Assets per Single Share Assertio|ASRT - Accounting Capitalization|Market Capitalization to Book Value Ratio assertiotx.com|ASRT - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Assertio Holdings, Inc.|ASRT - Long-Term Debt to Capital|Short-Term Debt to Equity Assertio Therapeutics|ASRT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Assertio Holdings, Inc.
Fundamental company valuation:assertiotx.com, ASRT
Manufactured products of Assertio Therapeutics

The book value per share, equal to 11.71, reflects the portion of net assets minus all liabilities, determining the intrinsic value of the security per unit. By analyzing the book value per share trend, an investor assesses the capitalization of the Assertio Holdings, Inc. (ASRT) drug portfolio, verifying how effectively the brand acquisition model and Indocin marketing convert into real equity growth.

Competitors of Assertio Holdings, Inc. (ASRT)

Net Assets per Single Share Biogen Corp (BIIB)|Neurocrine Corp (NBIX) - Accounting Value of a Share|RGC - Accounting Value per Share|AXSM (axsome.com) - Book Price of a Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Trevi Corp (TRVI) - Net Asset Value per Share|PRAX (Praxis Precision Medicines) - Book Value per Share|Book Value per Share AVXL|CBLL (CeriBell) - Net Assets per Single Share|Net Assets per Share PRTA (Prothena Corporation)|Net Assets per Single Share ALEC|Net Assets per Share Annexon Biosciences Inc. ANNX|OMER (Omeros Corp.) - Book Value per Share|NGNE: Net Asset Value per Share|Net Assets per Single Share AC Immune SA ACIU|Accounting Value of a Share Voyager Therapeutics Inc|Neumora Therapeutics Inc (NMRA) - Accounting Value per Share|Book Price of a Share Scilex Holding Company, Inc.|TVGN (Tevogen Bio Holdings) - Book Value per Share|Net Assets per Share ACOG (alphacognition.com)|CGTX: Net Assets per Single Share|IKT - Net Asset Value per Share|Accounting Value per Share Cassava (SAVA)|COYA - Accounting Value of a Share|Book Value per Share vistagen.com VTGN|OVID (Ovid Therapeutics) - Accounting Value of a Share|Net Assets per Single Share ABOS (Acumen Pharmaceuticals, Inc.)|Net Asset Value per Share CRVO|Net Assets per Single Share Alterity Therapeutics (ATHE)|Net Assets per Single Share clene.com (CLNN)|PEPG - Book Value per Share|Equity per Share Jupiter Neurosciences, Inc. JUNS|Book Value per Share RLMD (Relmada Therapeutics, Inc.)|ANVS: Net Assets per Share|Net Assets per Single Share gracetx.com|Firefly Neuro (AIFF) - Equity per Share|ANEW Medical - Book Value per Share|Book Value of One Share NRSN|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Net Assets per Single Share|Net Assets per Share metaviatx.com MTVA|Accounting Value per Share NeurAxis, Inc|Accounting Value of a Share Helius Medical Technologies, Inc. HSDT|Book Value per Share PASG (Passage Bio Corp)|NEUP: Net Assets per Share|Net Assets per Single Share Minerva Neurosciences, Inc.|Athira Pharma Inc (ATHA) - Equity per Share|Book Value per Share ADXN|Accounting Value per Share Alzamend (ALZN)|CYCN (Cyclerion Therapeutics) - Accounting Value per Share|Net Assets per Share protagenic.com (PTIX)|Book Value per Share KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc - Book Value per Share|Net Assets per Single Share ATXI (Avenue Therapeutics, Inc)|BCLI: Net Assets per Share|Net Assets per Single Share Cara Therapeutics, Inc. CARA|Accounting Value of a Share chromocell.com|Eliem Therapeutics, Inc. (ELYM) - Accounting Value per Share|Book Price of a Share ITCI|Net Assets per Single Share Longboard Pharma LBPH|Equity per Share Marinus Pharma (MRNS)|NKGN: Book Value per Share|NRBO - Net Asset Value per Share|Sage Therapeutics - Accounting Value per Share|SNPX: Book Value per Share|Net Assets per Single Share Trevena, Inc TRVN|VIGL (Vigil Neuroscience, Inc.) - Accounting Value of a Share|Net Assets per Single Share WENA (Anew Medical)|Net Asset Value per Share cerevel.com